Jeffrey V. Poulton - Insider Trading & Ownership

Entity
Individual
Location
300 Third Street, Cambridge, MA
Summary
The estimated net worth of Jeffrey V. Poulton is at least $7.72M dollars as of June 26, 2024. Jeffrey V. Poulton is the EVP, Chief Financial Officer of ALNYLAM PHARMACEUTICALS, INC. and owns shares of ALNYLAM PHARMACEUTICALS, INC. (ALNY) stock worth about $7.41M. Jeffrey V. Poulton is the Director of Homology Medicines, Inc. and owns shares of Q32 Bio Inc. (QTTB) stock worth about $309K.
All Insider Reports
All Insider Reports

Ownership of Jeffrey V. Poulton

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ALNY ALNYLAM PHARMACEUTICALS, INC. EVP, Chief Financial Officer $7.41M -$609K -7.59% Jun 24, 2024
QTTB Q32 Bio Inc. Director $309K Jun 14, 2023
CRVO CervoMed Inc. Director Jun 14, 2024

Insider Transactions Reported by Jeffrey V. Poulton:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.